Predatory Bacteria Are Nontoxic to the Rabbit Ocular Surface

Overview

Journal Sci Rep

Specialty Science

Date 2016 Aug 17

PMID 27527833

Citations 21

Authors

Eric G Romanowski

Nicholas A Stella

Kimberly M Brothers

Kathleen A Yates

Martha L Funderburgh

James L Funderburgh

Shilpi Gupta

Sonal Dharani

Daniel E Kadouri

Robert M Q Shanks

Affiliations

Soon will be listed here.

Abstract

Given the increasing emergence of antimicrobial resistant microbes and the near absent development of new antibiotic classes, innovative new therapeutic approaches to address this global problem are necessary. The use of predatory bacteria, bacteria that prey upon other bacteria, is gaining interest as an "out of the box" therapeutic treatment for multidrug resistant pathogenic bacterial infections. Before a new antimicrobial agent is used to treat infections, it must be tested for safety. The goal of this study was to test the tolerability of bacteria on the ocular surface using in vitro and in vivo models. Predatory bacteria Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus were found to be non-toxic to human corneal stromal keratocytes in vitro; however, they did induce production of the proinflammatory chemokine IL-8 but not IL-1β. Predatory bacteria did not induce inflammation on the ocular surface of rabbit eyes, with and without corneal epithelial abrasions. Unlike a standard of care antibiotic vancomycin, predatory bacteria did not inhibit corneal epithelial wound healing or increase clinical inflammatory signs in vivo. Together these data support the safety of predatory bacteria on the ocular surface, but future studies are warranted regarding the use predatory bacteria in deeper tissues of the eye.

Citing Articles

Predatory potentials of novel isolates against multidrug-resistant and extremely drug-resistant bacterial pathogens of animals and plants.

Selvaraj S, Gayathri S, Varalakshmi P, Nagarajan N, Palaniswami R, Ashokkumar B 3 Biotech. 2025; 15(3):69.

PMID: 40026678 PMC: 11868474. DOI: 10.1007/s13205-025-04230-8.

Predatory bacteria can intensify lung-injury in a multidrug-resistant pneumonia model in rat.

Mohsenipour Z, Kianian F, Jahanbin B, Abtahi H, Ghazanfari T, Edalatifard M Front Microbiol. 2025; 16:1512119.

PMID: 39916860 PMC: 11798975. DOI: 10.3389/fmicb.2025.1512119.

Predatory Bacteria in the Treatment of Infectious Diseases and Beyond.

Alexakis K, Baliou S, Ioannou P Infect Dis Rep. 2024; 16(4):684-698.

PMID: 39195003 PMC: 11354112. DOI: 10.3390/idr16040052.

Predatory bacteria prevent the proliferation of intraocular and fluoroquinolone-resistant .

Romanowski E, Brothers K, Calvario R, Stella N, Kim T, Elsayed M Microbiology (Reading). 2024; 170(2).

PMID: 38358321 PMC: 10924457. DOI: 10.1099/mic.0.001433.

Predatory bacteria as potential biofilm control and eradication agents in the food industry.

Mun W, Choi S, Upatissa S, Mitchell R Food Sci Biotechnol. 2023; 32(12):1729-1743.

PMID: 37780591 PMC: 10533476. DOI: 10.1007/s10068-023-01310-4.

References

Loryman C, Mansbridge J . Inhibition of keratinocyte migration by lipopolysaccharide. Wound Repair Regen. 2008; 16(1):45-51. DOI: 10.1111/j.1524-475X.2007.00290.x. View

Shanks R, Davra V, Romanowski E, Brothers K, Stella N, Godboley D . An Eye to a Kill: Using Predatory Bacteria to Control Gram-Negative Pathogens Associated with Ocular Infections. PLoS One. 2013; 8(6):e66723. PMC: 3688930. DOI: 10.1371/journal.pone.0066723. View

Altmann S, Emanuel A, Toomey M, McIntyre K, Covert J, Dubielzig R . A quantitative rabbit model of vaccinia keratitis. Invest Ophthalmol Vis Sci. 2010; 51(9):4531-40. PMC: 2941171. DOI: 10.1167/iovs.09-5106. View

Roach D, Donovan D . Antimicrobial bacteriophage-derived proteins and therapeutic applications. Bacteriophage. 2015; 5(3):e1062590. PMC: 4590002. DOI: 10.1080/21597081.2015.1062590. View

Thomashow M, RITTENBERG S . Intraperiplasmic growth of Bdellovibrio bacteriovorus 109J: solubilization of Escherichia coli peptidoglycan. J Bacteriol. 1978; 135(3):998-1007. PMC: 222476. DOI: 10.1128/jb.135.3.998-1007.1978. View

Snyder M, Bergmanson J, Doughty M . Keratocytes: no more the quiet cells. J Am Optom Assoc. 1998; 69(3):180-7. View

Brothers K, Stella N, Hunt K, Romanowski E, Liu X, Klarlund J . Putting on the brakes: Bacterial impediment of wound healing. Sci Rep. 2015; 5:14003. PMC: 4650533. DOI: 10.1038/srep14003. View

Carlet J, Pulcini C, Piddock L . Antibiotic resistance: a geopolitical issue. Clin Microbiol Infect. 2014; 20(10):949-53. DOI: 10.1111/1469-0691.12767. View

Shemesh Y, Jurkevitch E . Plastic phenotypic resistance to predation by Bdellovibrio and like organisms in bacterial prey. Environ Microbiol. 2003; 6(1):12-8. DOI: 10.1046/j.1462-2920.2003.00530.x. View

10.

Zowawi H, Harris P, Roberts M, Tambyah P, Schembri M, Pezzani M . The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015; 12(10):570-84. DOI: 10.1038/nrurol.2015.199. View

11.

Dwidar M, Monnappa A, Mitchell R . The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB Rep. 2012; 45(2):71-8. DOI: 10.5483/BMBRep.2012.45.2.71. View

12.

Shatzkes K, Chae R, Tang C, Ramirez G, Mukherjee S, Tsenova L . Examining the safety of respiratory and intravenous inoculation of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus in a mouse model. Sci Rep. 2015; 5:12899. PMC: 4528228. DOI: 10.1038/srep12899. View

13.

Dashiff A, Junka R, Libera M, Kadouri D . Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. J Appl Microbiol. 2010; 110(2):431-44. DOI: 10.1111/j.1365-2672.2010.04900.x. View

14.

Atterbury R, Hobley L, Till R, Lambert C, Capeness M, Lerner T . Effects of orally administered Bdellovibrio bacteriovorus on the well-being and Salmonella colonization of young chicks. Appl Environ Microbiol. 2011; 77(16):5794-803. PMC: 3165243. DOI: 10.1128/AEM.00426-11. View

15.

De Bentzmann S, Polette M, Zahm J, Hinnrasky J, Kileztky C, Bajolet O . Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab Invest. 2000; 80(2):209-19. DOI: 10.1038/labinvest.3780024. View

16.

Schwudke D, Linscheid M, Strauch E, Appel B, Zahringer U, Moll H . The obligate predatory Bdellovibrio bacteriovorus possesses a neutral lipid A containing alpha-D-Mannoses that replace phosphate residues: similarities and differences between the lipid As and the lipopolysaccharides of the wild type strain B..... J Biol Chem. 2003; 278(30):27502-12. DOI: 10.1074/jbc.M303012200. View

17.

Iebba V, Santangelo F, Totino V, Nicoletti M, Gagliardi A, De Biase R . Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects. PLoS One. 2013; 8(4):e61608. PMC: 3628794. DOI: 10.1371/journal.pone.0061608. View

18.

Gordon Y, Romanowski E, McDermott A . A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res. 2005; 30(7):505-15. PMC: 1497874. DOI: 10.1080/02713680590968637. View

19.

Lin C, Boehnke M . Effect of fortified antibiotic solutions on corneal epithelial wound healing. Cornea. 2000; 19(2):204-6. DOI: 10.1097/00003226-200003000-00014. View

20.

Brothers K, Stella N, Romanowski E, Kowalski R, Shanks R . EepR Mediates Secreted-Protein Production, Desiccation Survival, and Proliferation in a Corneal Infection Model. Infect Immun. 2015; 83(11):4373-82. PMC: 4598396. DOI: 10.1128/IAI.00466-15. View